Cargando…
The EVO ICL for Moderate Myopia: Results from the US FDA Clinical Trial
PURPOSE: To evaluate the safety and effectiveness of collamer posterior chamber phakic refractive lenses with a central port design (EVO and EVO+ Sphere and Toric implantable collamer lenses [ICLs]) for correction of moderate myopia with or without astigmatism. PATIENTS AND METHODS: Six-month result...
Autor principal: | Packer, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738966/ https://www.ncbi.nlm.nih.gov/pubmed/36510599 http://dx.doi.org/10.2147/OPTH.S393422 |
Ejemplares similares
-
Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial
por: Packer, Mark
Publicado: (2022) -
Relative position of the central hole after EVO-ICL implantation for moderate to high myopia
por: He, Xiaojian, et al.
Publicado: (2020) -
Primary observations of EVO ICL implantation for high myopia with concave iris
por: Zhang, Zhe, et al.
Publicado: (2023) -
Big-data and artificial-intelligence-assisted vault prediction and EVO-ICL size selection for myopia correction
por: Shen, Yang, et al.
Publicado: (2023) -
Performance and Safety of the Extended Depth of Focus Implantable Collamer(®) Lens (EDOF ICL) in Phakic Subjects with Presbyopia
por: Packer, Mark, et al.
Publicado: (2020)